Dr. Reddy's Laboratories Ltd. ADR sell Jefferies Financial Group Inc.
Start price
11.01.24
/
50%
€62.50
Target price
11.01.25
-
Performance (%)
-76.16%
End price
12.01.25
€14.90
Summary
This prediction ended on 12.01.25 with a price of €14.90. The SELL prediction by Jefferies_Financial_ for Dr. Reddy's Laboratories Ltd. ADR performed very well with a performance of -76.16%. Dividends of €0.44 are taken into consideration when calculating the performance. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | -4.918% | -4.918% | -7.937% |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% |
Comments by Jefferies_Financial_ for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to an "underperform" rating.
Ratings data for RDY provided by MarketBeat
In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten